Benvenue Medical minimally invasive spine device receives FDA clearance

Alan Condon -   Print  |

Benvenue Medical received FDA 510(k) clearance for its new minimally invasive expandable interbody device, Luna XD.

The device merges anterior lumbar interbody fusion principles with a minimally invasive controlled posterior approach to provide anterior column stability, strength and fusion in patients with degenerative disc disease.

It uses a small incision and offers a large implant footprint, which provides surgeons with a sizable graft chamber to achieve fusion success, height restoration and sagittal balance with minimal impaction, neural retraction or subsidence.

"In combination with our new Orbit discectomy platform, Luna XD demonstrates our core competency with material science and commitment to developing new products that will change the future of MIS lumbar fusion in both the hospital and increasingly, in the ASC setting," said Robert Weigle, CEO of Benvenue Medical.

More articles on devices:
Alphatec sees 3 organizational and corporate changes
Medtronic approves 8% quarterly dividend increase & more: 7 device company notes
Former spine surgeon Dr. Jeffrey Roh creates healthcare startup incubator

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies here.

Featured Webinars

Featured Whitepapers